T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Utah Medical Products
UTMD
$230M
| $26.1M | ﹤0.01% |
281,385
-245
| -0.1% | -$21.6K |
|
|
AKRO
1227
DELISTED
Akero Therapeutics
AKRO
| $25.7M | ﹤0.01% |
1,151,599
-2,604
| -0.2% | -$58.9K |
|
1228
Red Rock Resorts
RRR
$3.67B
| $25.6M | ﹤0.01% |
500,470
+484,775
| +3,089% | +$21.2M |
|
1229
Viatris
VTRS
$18.4B
| $25.6M | ﹤0.01% |
1,891,054
-42,013
| -2% | -$596K |
|
1230
A.O. Smith
AOS
$8.49B
| $25.6M | ﹤0.01% |
418,952
-3,900
| -0.9% | -$272K |
|
1231
Murphy USA
MUSA
$10.4B
| $25.4M | ﹤0.01% |
152,115
-3,356
| -2% | -$506K |
|
|
AGCUU
1232
DELISTED
Altimeter Growth Corp Unit
AGCUU
| $25.4M | ﹤0.01% |
2,386,351
-1,608,035
| -40% | -$17.9M |
|
1233
Wabtec
WAB
$50.3B
| $25.4M | ﹤0.01% |
294,360
-4,307
| -1% | -$371K |
|
|
ABCM
1234
DELISTED
Abcam PLC
ABCM
| $25.3M | ﹤0.01% |
1,248,156
+857
| +0.1% | +$17.1K |
|
|
K
1235
DELISTED
Kellanova
K
| $25.2M | ﹤0.01% |
420,281
-10,723
| -2% | -$643K |
|
1236
Seagate
STX
$209B
| $25.2M | ﹤0.01% |
305,374
-5,644
| -2% | -$491K |
|
1237
Principal Financial Group
PFG
$24.6B
| $25.1M | ﹤0.01% |
389,027
-6,003
| -2% | -$385K |
|
|
BLFY
1238
DELISTED
Blue Foundry Bancorp
BLFY
| $24.9M | ﹤0.01% |
+1,805,374
| New | +$24.2M |
|
|
IAS
1239
DELISTED
Integral Ad Science
IAS
| $24.8M | ﹤0.01% |
1,203,284
+203,284
| +20% | +$4.01M |
|
1240
Haemonetics
HAE
$4.11B
| $24.8M | ﹤0.01% |
351,265
-205,049
| -37% | -$12.9M |
|
1241
First Bancorp
FBNC
$2.74B
| $24.8M | ﹤0.01% |
576,451
-5,141
| -0.9% | -$209K |
|
1242
H.B. Fuller
FUL
$3.24B
| $24.8M | ﹤0.01% |
383,593
-6,340
| -2% | -$411K |
|
1243
W.P. Carey
WPC
$16.3B
| $24.7M | ﹤0.01% |
345,542
-262,857
| -43% | -$20M |
|
|
EXE
1244
Expand Energy Corp
EXE
$21.9B
| $24.7M | ﹤0.01% |
400,512
-1,499,623
| -79% | -$84.1M |
|
1245
BlackLine
BL
$1.82B
| $24.5M | ﹤0.01% |
207,527
-3,247
| -2% | -$373K |
|
1246
Clearway Energy Class C
CWEN
$7.02B
| $24.5M | ﹤0.01% |
809,164
-400,525
| -33% | -$11.9M |
|
1247
Five Star Bancorp
FSBC
$1.16B
| $24.2M | ﹤0.01% |
1,012,745
+605,299
| +149% | +$14.5M |
|
1248
DaVita
DVA
$11.4B
| $24.1M | ﹤0.01% |
207,393
-1,800
| -0.9% | -$225K |
|
|
DADA
1249
DELISTED
Dada Nexus
DADA
| $23.9M | ﹤0.01% |
+1,190,959
| New | +$27M |
|
1250
Boston Properties
BXP
$11B
| $23.7M | ﹤0.01% |
218,511
-2,905
| -1% | -$332K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.